Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs PlushCare

HealthRX
Graded #8

Higher grade

vs+11.599999999999994
PlushCare
Graded #63

Lower grade

The verdict

HealthRX takes it — 86.1/100 to 74.5/100.

HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthRX +11
85
74
Dose & formulationHealthRX +13
90
77
Clinical oversightHealthRX +5
87
82
Labs & monitoringHealthRX +5
82
77
FulfillmentHealthRX +8
86
78
Contract termsHealthRX +44
85
41
HealthRX · left barPlushCare · right bar

The numbers

MetricHealthRXPlushCare
WeighScore86.1/10074.5/100
GradeBC
Scorecard rank#8#63
Semaglutide$189/mo$149/mo (starting dose, compounded)
Tirzepatide$349/mo$399/mo (starting dose, compounded)
CoverageNot publicly listedAll 50 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
HealthRX

Graded #8 · B

Strengths

  • LegitScript-certified (#50087439) — a genuine, verifiable trust signal
  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed
PlushCare

Graded #63 · C

Strengths

  • Available in all 50 states
  • Appointments with US board-certified physicians, not nurse practitioners only
  • Virtual primary care — the same doctor can manage GLP-1s alongside other health needs
  • Owned by Transcarent, a venture-backed health platform with a named corporate parent

Where it loses points

  • Facing a California class action alleging deceptive subscription enrollment and unauthorized charges after cancellation
  • GLP-1 prescribing is up to the clinician at the visit — not guaranteed at signup
  • BBB complaints center on the membership cancellation process

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard